Please use this identifier to cite or link to this item:
Title: Perioperative use of prothrombin complex concentrates
Author: Colomina Soler, M. J. (María José)
Díez Lobo, A.
Garutti, I.
Gómez-Luque, A.
Llau, Juan Vicente
Pita, E.
Keywords: Coagulació sanguínia
Plasma sanguini
Anticoagulants (Medicina)
Cirurgia operatòria
Blood coagulation
Blood plasma
Anticoagulants (Medicine)
Operative surgery
Issue Date: Mar-2012
Publisher: Edizioni Minerva Medica
Abstract: Prothrombin complex concentrates (PCCs) are purified drug products with hemostatic activity derived from a plasma pool. Today, PCCs contain a given and proportional amount of four non-activated vitamin K-dependent coagulation factors (II, VII, IX, and X), a variable amount of anticoagulant proteins (proteins C and S, and in some antithrombin) and low-dose heparin. In some countries PCC products contained only three clotting factors, II, IX, and X. Dosage recommendations are based on IU of F-IX, so that one IU of F-IX represents the activity of F-IX in 1 mL of plasma. Reversion of the anticoagulant effect of vitamin K antagonists (VKAs) in cases of symptomatic overdose, active bleeding episodes, or need for emergency surgery is the most important indication for PCCs and this effect of PCCs appears to be more complete and rapid than that caused by administration of fresh frozen plasma. They may be considered as safe preparations if they are used for their approved indications at the recommended dosage with adequate precautions for administration, and have been shown to be effective for reversing the effect of VKAs. Their adequate use based on decision algorithms in the perioperative setting allows a rapid normalization of International Normalized Ratio (INR) for performing emergency surgery, minimizing bleeding risk. This review aims to propose two algorithms for the use of PCCs in the perioperative setting, one to calculate the PCCs dose to be administered in a bleeding patient and/or immediately before urgent surgery, based on patient's clinical status, prior INR and INR target and another for reversing the action of oral anticoagulants depending on urgency of surgery.
Note: Versió postprint del document publicat a:
It is part of: Minerva Anestesiologica, 2012, vol. 78, num. 3, p. 358-368
ISSN: 0375-9393
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
665048.pdf760.91 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.